Evidence map›Paper›PMID 26795413›Full record

Trial reportEye (London, England)2016

The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II UK Trial.

R B R Moreton, B W Fleck, A R Fielder, C A Williams, L Butler, C Wilson, K Cocker, E Juszczak, A King, B Stenson and 2 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Eye (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

R B R MoretonAcademic Foundation Programme Trainee, Edinburgh, UK.
B W FleckPrincess Alexandra Eye Pavilion, Edinburgh, UK.
A R FielderDepartment of Optometry and Visual Science, City University, London, UK.
C A WilliamsDepartment of Ophthalmology, Bristol Eye Hospital, Bristol, UK.
L ButlerDepartment of Ophthalmology, Birmingham and Midland Eye Hospital, Birmingham, UK.
C WilsonDepartment of Ophthalmology, Chelsea and Westminster Hospital, London, UK.
K Cockerwww.visionresearch.org, Birmingham, UK.
E JuszczakBOOST-II UK Collaborative Group, National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK.
A KingBOOST-II UK Collaborative Group, National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK.
B StensonNeonatal Intensive Care Unit, Royal Infirmary, Edinburgh, UK.
P BrocklehurstInstitute for Women's Health, University College London, London, UK.
BOOST-II UK Collaborative Group
Oxford Research Group · GBCity, University of London · GBBirmingham and Midland Eye Centre · GBBristol Eye Hospital · GBChelsea and Westminster Hospital · GBEdinburgh Royal Infirmary · GBPrincess Alexandra Eye Pavilion · GBUniversity of Oxford · GB

Funding

Medical Research Council G0400415
6 · The paper itself

Abstract

purposeRetinopathy of prematurity (ROP) is a disorder of developing retinal blood vessels in preterm infants. The purpose of this nested study was to investigate the effects of higher (91-95%) and lower (85-89%) oxygen saturation (SpO2) targeting on retinal blood vessel growth in preterm infants.

methodsRetinal blood vessel growth in the higher (91-95%) and lower (85-89%) oxygen saturation (SpO2) targeting groups was compared. Suitable RetCam (Clarity, Pleasanton, CA, USA) images collected in the BOOST-II UK trial were used. The distances between the centre of the optic disc and the ROP ridge in the temporal and nasal retina were measured in pixel units.

resultsImages from 38 infants were studied, 20 from the higher SpO2 target group and 18 from the lower SpO2 target group. On average, temporal blood vessels extended further from the optic disc than nasal blood vessels, mean (standard deviation (SD)) 463.39 (55.05) pixels compared with 360.13 (44.47) pixels, respectively, P<0.0001. Temporal blood vessels extended less far from the optic disc in the higher SpO2 target group than in the lower SpO2 target group: mean (SD) 449.83 (56.16) pixels compared with 480.02 (49.94), respectively, P=0.055. Nasal retinal blood vessel measurements were broadly similar in the higher and lower SpO2 target groups; mean (SD) 353.96 (41.95) compared with 370.00 (48.82) pixels, respectively, P=0.38.

conclusionsRelatively high oxygen saturation targeting (91-95%) was associated with a trend (P=0.055) towards reduced retinal blood vessel growth in this study of preterm infants.

Indexed as

Oxygen Inhalation TherapyDatabases, FactualFemaleGestational AgeHumansInfantInfant, NewbornInfant, PrematureInfant, Very Low Birth WeightMaleObserver VariationOximetryOxygenRetinal NeovascularizationRetinal VesselsRetinopathy of PrematurityOxygen

Identifiers

PMID26795413
PMCPMC4834037
OpenAlexW2285587701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.